California Stem Cell, Inc. announced today the successful completion of a Phase I clinical trial investigating the safety of a cancer stem cell-based therapy in patients with Stage IV hepatocellular carcinoma, a common form of advanced liver cancer.
http://www.businesswire.com/news/topix/20131218005574/en
http://www.businesswire.com/news/topix/20131218005574/en
No comments:
Post a Comment